Werewolf Therapeutics Inc

NASDAQ:HOWL   2:09:03 PM EDT
3.88
-0.30 (-7.18%)
Earnings Announcements

Werewolf Therapeutics Reports First Quarter 2022 Financial Results And Provides Business Highlights

Published: 05/10/2022 11:43 GMT
Werewolf Therapeutics Inc (HOWL) - Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights.
Qtrly Net Loss per Share $0.56.
As of March 31, 2022, Cash and Cash Equivalents Were $143.7 Million.
Q1 Earnings per Share View $-0.62 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.75 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.